Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1,651–1,675 of 7,816 matching trials · page 67 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases NCT02649985 [F-18]PBR06; [C-11]PBR28 Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 250 | Brigham and Women's Hospital OTHER |
2026-01-28 |
|
MEMORI Corps: Activity-based Companion Care for Dementia NCT03896711 MEMORI Corps program; Augmented Waitlist Control Runs in: United States · 1 site |
NA other |
COMPLETED | 175 | Johns Hopkins University OTHER |
2026-01-28 |
|
Nabilone for Agitation Blinded Intervention Trial NCT04516057 Nabilone; Placebo Runs in: Canada · 6 sites |
PHASE3 other |
RECRUITING | 112 | Sunnybrook Health Sciences Centre OTHER |
2026-01-28 |
|
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department NCT05974527 Sublingual film containing dexmedetomidine (BXCL501) |
PHASE4 other |
WITHDRAWN | 0 | Brigham and Women's Hospital OTHER |
2026-01-28 |
|
Anti-Diabetic Medications to Fight PD and LBD NCT06263673 Sitagliptin; Dapagliflozin; Placebo Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 18 | Mayo Clinic OTHER |
2026-01-28 |
|
Feasibility of Lecanemab Registry and Clinical Outcome Measures NCT06285448 Lecanemab Runs in: United States · 1 site |
NA anti-amyloid-antibody |
ENROLLING_BY_INVITATION | 20 | HealthPartners Institute OTHER |
2026-01-28 |
|
Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance NCT07220694 Sabroxy®; Placebo Runs in: United States · 1 site |
NA other |
RECRUITING | 140 | SF Research Institute, Inc. NETWORK |
2026-01-28 |
|
Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise NCT07321587 ACTIVE Intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 100 | NYU Langone Health OTHER |
2026-01-28 |
|
Health enSuite Caregivers: an App-based Treatment for Distressed Caregivers of Persons With Moderate Dementia NCT04944420 Health enSuite Caregivers |
NA other |
NOT_YET_RECRUITING | 400 | IWK Health Centre OTHER |
2026-01-27 |
|
Keeping on Course: A Communication-Focused Psychoeducational Program NCT05423912 Keeping on Course Program Runs in: United States · 1 site |
NA other |
COMPLETED | 29 | Emory University OTHER |
2026-01-27 |
|
Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement NCT05614986 5 minute Montreal Cognitive Assessment (mini MoCA) Runs in: United States · 4 sites |
NA other |
COMPLETED | 81 | Baylor Research Institute OTHER |
2026-01-27 |
|
Epileptic Hippocampus in Alzheimer's Disease NCT05899764 Brivaracetam Runs in: United States · 1 site |
PHASE1|PHASE2 other |
NOT_YET_RECRUITING | 25 | University of California, Los Angeles OTHER |
2026-01-27 |
|
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK NCT06372821 NIO752; Placebo Runs in: United Kingdom; United States · 2 sites |
PHASE1 other |
RECRUITING | 10 | University College, London OTHER |
2026-01-27 |
|
Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease NCT03136679 Runs in: United States · 1 site |
NA other |
COMPLETED | 95 | Baylor Research Institute OTHER |
2026-01-26 |
|
Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment NCT05289804 NITESGON; Lidocaine / Prilocaine Topical Cream; C5/C6 stimulation; ... Runs in: Ireland · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 80 | University of Dublin, Trinity College OTHER |
2026-01-26 |
|
Sweet Night (Musical Diffusion by Caregivers ): Effects of Musical Diffusion by Caregivers on Sleep Onset and Behavioral Regulation in a Protected Living NCT07207642 Music intervention - passive listening; Audio books intervention - ... Runs in: France · 1 site |
NA other |
RECRUITING | 120 | Centre Hospitalier Universitaire de Saint Etienne OTHER |
2026-01-26 |
|
Effects of Virtual Reality Dementia Education on College Students' Knowledge and Attitudes NCT07366073 VR-360 Dementia Education; CG VR Dementia Education Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 129 | Asia University OTHER |
2026-01-26 |
|
Biomarker Exploration in Aging, Cognition and Neurodegeneration NCT03860857 Amyloid PET scan; Tau PET scan using MK-6240; Neurocognitive testing; MRI Runs in: United States · 1 site |
PHASE3 other |
RECRUITING | 300 | University of California, Irvine OTHER |
2026-01-23 |
|
Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities NCT05273320 Nabilone Runs in: Canada · 1 site |
PHASE1 other |
COMPLETED | 20 | Hsiang-Yuan Lin OTHER |
2026-01-23 |
|
Self-Care for Dementia Caregivers NCT05309577 Behavioral Self-Monitoring + Motivational Interviewing Runs in: United States · 1 site |
NA other |
COMPLETED | 21 | University of Pittsburgh OTHER |
2026-01-23 |
|
EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment NCT05790707 Atrial fibrillation ablation + antiarrhythmic drugs; Antiarrhythmic drug Runs in: France · 8 sites |
NA other |
RECRUITING | 120 | Poitiers University Hospital OTHER |
2026-01-23 |
|
A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab NCT06322667 No Intervention Runs in: Japan · 3 sites |
NA anti-amyloid-antibody |
RECRUITING | 5,000 | Eisai Co., Ltd. INDUSTRY |
2026-01-23 |
|
Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles. NCT07361887 White Wine; Red Wine; Water Runs in: Spain · 1 site |
NA other |
RECRUITING | 8 | University of Seville OTHER |
2026-01-23 |
|
A Digital Cognitive Behavioural Therapy for Insomnia Intervention in Mild Cognitive Impairment and Mild Dementia NCT07363928 Digital cognitive behavioural therapy for insomnia Runs in: Ireland · 1 site |
NA other |
COMPLETED | 30 | University College Cork OTHER |
2026-01-23 |
|
Digital Interventions in Neuro-Rehabilitation: Gotcha! NCT04570215 Gotcha! Therapy application; Gotcha Therapy application: Maintenance Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 48 | University College, London OTHER |
2026-01-22 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial